Somatostatin-25 is primarily used in medical and research settings due to its role in regulating various physiological processes. It is often applied in studies related to hormone secretion, particularly in inhibiting the release of growth hormone, insulin, and glucagon. This makes it valuable in understanding and managing conditions like acromegaly, diabetes, and certain gastrointestinal disorders. Additionally, it is utilized in diagnostic tests to assess endocrine function. In clinical practice, analogs of Somatostatin-25 are employed to treat neuroendocrine tumors by slowing their growth and reducing symptoms caused by excessive hormone production. Its application extends to research in neuroscience, where it helps investigate its effects on neurotransmission and brain function.